Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 3
1995 5
1996 7
1997 9
1998 19
1999 48
2000 34
2001 38
2002 45
2003 34
2004 40
2005 36
2006 38
2007 26
2008 35
2009 36
2010 33
2011 48
2012 52
2013 47
2014 46
2015 38
2016 45
2017 47
2018 44
2019 52
2020 42
2021 39
2022 31
2023 33
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

955 results

Results by year

Filters applied: . Clear all
Page 1
Repaglinide.
[No authors listed] [No authors listed] 2019 Feb 7. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2019 Feb 7. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000151 Free Books & Documents. Review.
No information is available on the use of repaglinide during breastfeeding. Repaglinide is a weak acid that is over 98% protein bound, so it is unlikely to pass into breastmilk in clinically important amounts. ...If there is concern, monitoring of the breastfed infa …
No information is available on the use of repaglinide during breastfeeding. Repaglinide is a weak acid that is over 98% protei …
Pharmacogenomics of glinides.
Chen M, Hu C, Jia W. Chen M, et al. Pharmacogenomics. 2015 Jan;16(1):45-60. doi: 10.2217/pgs.14.152. Pharmacogenomics. 2015. PMID: 25560470 Review.
Glinides, including repaglinide, nateglinide and mitiglinide, are a type of fasting insulin secretagogue that could help to mimic early-phase insulin release, thus providing improved control of the postprandial glucose levels. ...
Glinides, including repaglinide, nateglinide and mitiglinide, are a type of fasting insulin secretagogue that could help to mimic ear …
Repaglinide.
Balfour JA, Faulds D. Balfour JA, et al. Drugs Aging. 1998 Aug;13(2):173-80. doi: 10.2165/00002512-199813020-00008. Drugs Aging. 1998. PMID: 9739505 Review.
Repaglinide is rapidly absorbed and eliminated, which may allow a relatively fast onset and offset of action. ...Addition of repaglinide to existing metformin therapy resulted in improved glycaemic control. ...
Repaglinide is rapidly absorbed and eliminated, which may allow a relatively fast onset and offset of action. ...Addition of repag …
Repaglinide: a review of its use in type 2 diabetes mellitus.
Scott LJ. Scott LJ. Drugs. 2012 Jan 22;72(2):249-72. doi: 10.2165/11207600-000000000-00000. Drugs. 2012. PMID: 22268393 Review.
Oral repaglinide (GlucoNorm; NovoNorm; Prandin; Surepost) is a rapid-acting insulin secretagogue that lowers postprandial glucose (PPG) excursions by targeting early-phase insulin release, with reductions in PPG considered to be important in reducing long-term cardi …
Oral repaglinide (GlucoNorm; NovoNorm; Prandin; Surepost) is a rapid-acting insulin secretagogue that lowers postprandial gluc …
Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits.
Hadi NR, Al-Amran F, Hussein MA, Rezeg FA. Hadi NR, et al. J Cardiovasc Dis Res. 2012 Jan;3(1):5-11. doi: 10.4103/0975-3583.91592. J Cardiovasc Dis Res. 2012. PMID: 22346138 Free PMC article.
Some results from the literature demonstrate that repaglinide has favorable effects on the parameters of antioxidative balance. OBJECTIVES: The objective of the present study was to assess the effect of glimepiride and repaglinide on atherosclerosis via interfering …
Some results from the literature demonstrate that repaglinide has favorable effects on the parameters of antioxidative balance. OBJEC …
Development of anti-acanthamoebic approaches.
Mungroo MR, Tong T, Khan NA, Anuar TS, Maciver SK, Siddiqui R. Mungroo MR, et al. Int Microbiol. 2021 Aug;24(3):363-371. doi: 10.1007/s10123-021-00171-3. Epub 2021 Mar 23. Int Microbiol. 2021. PMID: 33754231
The results indicated that acarbose, indaziflam, terbuthylazine, glimepiride, inositol, vildagliptin and repaglinide showed anti-amoebic effects. Compounds showed minimal toxicity on human cells. ...
The results indicated that acarbose, indaziflam, terbuthylazine, glimepiride, inositol, vildagliptin and repaglinide showed anti-amoe …
Pharmacology and clinical experience with repaglinide.
Massi-Benedetti M, Damsbo P. Massi-Benedetti M, et al. Expert Opin Investig Drugs. 2000 Apr;9(4):885-98. doi: 10.1517/13543784.9.4.885. Expert Opin Investig Drugs. 2000. PMID: 11060717 Review.
Repaglinide (NovoNorm((R))) is a novel oral antidiabetic agent, the first of a new class of insulin secretagogues known as the prandial glucose regulators to be approved for use in patients with Type 2 diabetes. ...Repaglinide is quickly absorbed and rapidly …
Repaglinide (NovoNorm((R))) is a novel oral antidiabetic agent, the first of a new class of insulin secretagogues known as the …
[Repaglinide].
Quast U. Quast U. Dtsch Med Wochenschr. 2001 May 11;126(19):559-60. doi: 10.1055/s-2001-13801. Dtsch Med Wochenschr. 2001. PMID: 11402913 German. No abstract available.
New treatments for patients with type 2 diabetes mellitus.
Wolffenbuttel BH, Graal MB. Wolffenbuttel BH, et al. Postgrad Med J. 1996 Nov;72(853):657-62. doi: 10.1136/pgmj.72.853.657. Postgrad Med J. 1996. PMID: 8944206 Free PMC article. Review.
A new class of drugs with insulin secretory capacity, of which repaglinide (NovoNorm) is the leading compound, is now in phase III clinical trials. ...
A new class of drugs with insulin secretory capacity, of which repaglinide (NovoNorm) is the leading compound, is now in phase …
Hypersensitivity to repaglinide.
Rojas P, Sánchez L, Santos A, Góõmez MP, Blanco H, Laguna JJ. Rojas P, et al. J Investig Allergol Clin Immunol. 2011;21(3):245-7. J Investig Allergol Clin Immunol. 2011. PMID: 21548456 Free article.
Meglitinides (repaglinide and nateglinide) are insulin secretagogues used to treat diabetes mellitus. We present a case of hypersensitivity reaction to repaglinide in a 61-year-old man who developed a maculopapular rash 5 days after treatment. ...
Meglitinides (repaglinide and nateglinide) are insulin secretagogues used to treat diabetes mellitus. We present a case of hypersensi …
955 results